Akorn, Inc. is recalling 264 bottles of Betamethasone Dipropionate Lotion USP (Augmented), 0.05%, a prescription topical medication used to treat skin conditions. This recall was initiated because testing detected an unknown impurity that exceeded the product's quality specifications, which may affect the drug's safety and effectiveness. The recall affects both 30 mL and 60 mL bottles distributed nationwide across the United States.
The presence of an unknown impurity or degradation product means the medication does not meet its approved quality standards, which could potentially cause skin irritation or reduced effectiveness of the treatment.
Pharmacy refund and healthcare consultation.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.